Cost & insurance review · Updated July 2026
How much does menopause treatment cost?
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP
Quick answer
$5-$300/mo. Menopause treatment costs $5-$300/month depending on regimen, insurance, and delivery route. Generic HRT (estradiol + progesterone) covers most patients at $5-$40/month insured or $33/month cash-pay via Cost Plus Drugs. Subscription telehealth bundles $49-$99/month. Compounded bioidentical HRT and specialty adjunct therapies (testosterone, vaginal estrogen) can push totals higher.
Price ranges by tier
What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.
Generic FDA-approved HRT (insured)
$5-$40/mo- Estradiol patch + micronized progesterone
- Tier 1-2 formulary copay
Generic FDA-approved HRT (cash)
$33-$80/mo- Cost Plus Drugs $33/mo total
- GoodRx retail cash $47-$80/mo
Subscription telehealth bundle
$49-$99/mo- Alloy, Evernow, Winona
- Consult + medication included
Brand-name HRT
$40-$120/mo insured- Climara, Vivelle-Dot, Estrace
- Manufacturer copay cards may apply
Compounded bioidentical
$80-$300/mo- Cash-only
- Not FDA-approved
- Same active hormones as generic
Baseline lab panel
$80-$200 one-time- FSH, estradiol, TSH, lipid panel
Factors that affect cost
- Insurance status and plan formulary
- Choice of FDA-approved generic vs compounded bioidentical
- Whether you bundle with a subscription platform
- Add-on therapies (testosterone, vaginal estrogen, mental health)
- Frequency of clinical follow-up
- Baseline and annual lab bundle
Insurance context
Most US commercial insurers and Medicare Part D cover FDA-approved HRT (estradiol patches/gels, oral estradiol, micronized progesterone) at generic drug tiers. Prior authorization may apply to specific brand formulations. Compounded bioidentical HRT is almost universally excluded. Some plans require documented menopause diagnosis or physician-documented failure of alternative therapies for prior authorization.
Financial help options
- Cost Plus Drugs ↗: Generic estradiol and progesterone at transparent cash prices ($11 + $22 = $33/mo).
- GoodRx / SingleCare: Cash coupons reduce retail pharmacy prices by 40-60%.
- Manufacturer copay cards: Brand HRT (Climara, Estring) offer commercial-insurance copay reduction to $10-$25/mo.
- HSA/FSA accounts: Cover FDA-approved HRT, telehealth visits, and compounded HRT with letter of medical necessity.
- FQHC sliding-scale ↗: For low-income patients: $25-$80 per visit + generic HRT prescribing.
Related brands
Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.
Related questions
Frequently asked questions
- How much does a year of menopause treatment cost?
- A full year of cash-pay menopause care (telehealth + generic HRT + labs) totals $400-$1,200. With insurance, generic HRT alone can be as low as $60-$500/year depending on copay tier and visit frequency.
- Does insurance cover HRT for menopause?
- Most US commercial insurers and Medicare Part D cover FDA-approved HRT for vasomotor symptoms. Compounded bioidentical HRT is almost universally excluded. Some plans require prior authorization.
- What is the cheapest form of menopause treatment?
- Generic estradiol patch + generic micronized progesterone via Cost Plus Drugs ($33/mo total) is the cheapest FDA-approved regimen. Add a quarterly telehealth subscription for a comprehensive care package.
- Do I need labs before starting HRT?
- Baseline labs are recommended but not strictly required. Most guidelines suggest FSH, estradiol, TSH, and a lipid panel. Cash-pay DTC options run $80-$200. Many telehealth subscription platforms include initial labs.
Sources
Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.
Related cost questions
ClearHormones publishes editorial pricing research quarterly. Pricing may change without notice — always confirm current terms on the manufacturer or brand pricing page before purchasing.